Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells

被引：0

作者：

Kurihara, E. ^{[1
]}

Shien, K. ^{[1
]}

Torigoe, H. ^{[1
]}

Takahashi, Y. ^{[1
]}

Ogoshi, Y. ^{[1
]}

Yoshioka, T. ^{[1
]}

Namba, K. ^{[1
]}

Sato, H. ^{[1
]}

Yamamoto, H. ^{[1
]}

Soh, J. ^{[1
]}

Toyooka, S. ^{[1
]}

机构：

[1] Okayama Univ, Gen Thorac Surg & Breast & Endocrinol Surg, Okayama, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

HSP90; inhibitor; drug resistance;

D O I：

10.1016/j.jtho.2018.08.870

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.13-13

引用

页码：S586 / S587

页数：2

共 40 条

[21] mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy
Zheng, Yan
Su, Chang
Zhao, Liang
Shi, Yijie
JOURNAL OF NANOBIOTECHNOLOGY, 2017, 15
[22] Chemosensitizing effect and mechanism of imperatorin on the anti-tumor activity of doxorubicin in tumor cells and transplantation tumor model
Liang, Xin-li
Ji, Miao-miao
Liao, Zheng-gen
Zhao, Guo-wei
Tang, Xi-lan
Dong, Wei
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2022, 26 (03): : 145 - 155
[23] A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance
Zheng, Qiyao
Dong, Hui
Mo, Jianshan
Zhang, Yi
Huang, Jie
Ouyang, Shumin
Shi, Shuo
Zhu, Kai
Qu, Xinming
Hu, Wenhao
Liu, Peiqing
Wang, Yuanxiang
Zhang, Xiaolei
THERANOSTICS, 2021, 11 (02): : 824 - 840
[24] Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo
Xu, Dong-Qing
Toyoda, Hidemi
Yuan, Xiao-Jun
Qi, Lei
Chelakkot, Vipin Shankar
Morimoto, Man
Hanaki, Ryo
Kihira, Kentarou
Hori, Hiroki
Komada, Yoshihiro
Hirayama, Masahiro
EXPERIMENTAL CELL RESEARCH, 2018, 365 (02) : 177 - 184
[25] Valproic Acid Enhances the Anti-tumor Effect of (-)-gossypol to Burkitt Lymphoma Namalwa Cells
Gong Yi
Ni Zhen Hong
Zhang Xi
Chen Xing Hua
Zou Zhong Min
BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2015, 28 (10) : 773 - 777
[26] Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
Del Re, Marzia
Tiseo, Marcello
Bordi, Paola
D'Incecco, Armida
Camerini, Andrea
Petrini, Iacopo
Lucchesi, Maurizio
Inno, Alessandro
Spada, Daniele
Vasile, Enrico
Citi, Valentina
Malpeli, Giorgio
Testa, Enrica
Gori, Stefania
Falcone, Alfredo
Amoroso, Domenico
Chella, Antonio
Cappuzzo, Federico
Ardizzoni, Andrea
Scarpa, Aldo
Danesi, Romano
ONCOTARGET, 2017, 8 (08) : 13611 - 13619
[27] Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition
Zhou, Juan
Hu, Qiaoting
Zhang, Xi
Zheng, Jihua
Xie, Bo
Xu, Zhiyong
Zhang, Weimin
ONCOLOGY REPORTS, 2018, 39 (04) : 1783 - 1792
[28] Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer
Wu, Meng
Cui, Jingyi
Hou, Huimin
Li, Ying
Liu, Shengjie
Wan, Li
Zhang, Lili
Huang, Wei
Sun, Gaoyuan
Liu, Jingchao
Jin, Pengfei
He, Shunmin
Liu, Ming
FRONTIERS IN PHARMACOLOGY, 2022, 13
[29] The miR-625-3p/AXL axis induces non-T790M acquired resistance to EGFR-TKI via activation of the TGF-β/Smad pathway and EMT in EGFR-mutant non-small cell lung cancer
Du, Wenwen
Sun, Lin
Liu, Ting
Zhu, Jianjie
Zeng, Yuanyuan
Zhang, Yang
Wang, Xueting
Liu, Zeyi
Huang, Jian-An
ONCOLOGY REPORTS, 2020, 44 (01) : 185 - 195
[30] A Novel Compound NSC745885 Exerts an Anti-Tumor Effect on Tongue Cancer SAS Cells In Vitro and In Vivo
Chen, Yuan-Wu
Huang, Hsu-Shan
Shieh, Yi-Shing
Ma, Kuo-Hsing
Huang, Shing-Hwa
Hueng, Dueng-Yuan
Sytwu, Huey-Kang
Lin, Gu-Jiun
PLOS ONE, 2014, 9 (08):

← 1 2 3 4 →